VOR BIOPHARMA
Vor Biopharma is an immuno-oncology company that develops therapies for treating cancer. It is focused on developing technologies that can enable selective targeting of cancer cells without impacting normal cells. Cell surface-targeted immunotherapies, such as bispecific antibodies, antibody-drug conjugates, and chimeric antigen receptor (CAR) T cells, generally target both cancer and normal cells, causing substantial toxicities and limiting their potential. The company is taking a fundamental... ly novel approach to targeting cancer selectively by developing hematopoietic stem cells (HSCs) that have been engineered to be protected from specifically targeted immunotherapies. These HSCs are designed to generate healthy, functional cells that are also protected from depletion by cancer-targeted therapies.
VOR BIOPHARMA
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2016-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.vorbio.com
Total Employee:
51+
Status:
Active
Contact:
617-655-6580
Email Addresses:
[email protected]
Total Funding:
152 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Amazon Office 365 Mail IPv6 Microsoft Azure DNS GoDaddy DNS Google Google Cloud Amazon Route 53
Similar Organizations
Aerin Medical
Aerin Medical is a health technology company that develops therapeutic devices to improve nasal breathing.
Rakuten Medical
Rakuten Medical is a Bio-technology Company.
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
Avrobio
Avrobio is a clinical stage company developing step-change cell and gene therapies targeting cancer and rare disease.
Bolt Biotherapeutics
Bolt Biotherapeutics is a biotechnology company that develops a platform for cancer immunotherapy.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Cytlimic
CYTLIMIC is a biotechnology company that develops immunotherapy products for the treatment of cancer, including a cancer peptide vaccine.
Day One Biopharmaceuticals
Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.
Encodia
Encodia is a biotech company that develops the next generation of protein analysis tools.
Fount Bio
Fount Bio is a life science company that applies proprietary advances in glycopolymer research for skin health.
GamaMabs Pharma
GamaMabs Pharma is a clinical-stage immuno-oncology company that developes optimized therapeutic antibodies for the treatment of cancer.
ImmPACT Bio
ImmPACT Bio USA is developing novel cell therapies for treating cancer.
Kindred Biosciences
Kindred Biosciences is a veterinary biotechnology company that focuses on developing therapies for dogs, cats and horses.
Korro Bio
Korro Bio provides an efficient and selective method for RNA editing, leveraging natural processes common to all multi-cellular organisms.
MONTKUSH
MONTKUSH is an agriculture company that develops exclusive farms to oil CBD extract that is 100% organic.
NowRx
NowRx is a pharmacy and last-mile logistics company that provides same-day and same-hour prescription medication delivery.
Oncorus
Oncorus is an immuno-oncology company developing oncolytic viruses to fight cancer.
PharmaCielo
PharmaCielo is a global company privately held and headquartered in Canada.
QSimulate
QSimulate is leveraging the power of quantum mechanics to solve industrial-scale problems like never before.
Radius Health
Radius Health develops drug therapies for osteoporosis and women’s health.
Soteria Biotherapeutics
Soteria is a biotechnology company that develops immunotherapies to treat cancer patients
Toregem BioPharma
Toregem BioPharma is a startup from Kyoto University that develops a treatment for congenital adentia.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Fidelity Management and Research Company
Fidelity Management and Research Company investment in Series B - Vor Biopharma
OUP (Osage University Partners)
OUP (Osage University Partners) investment in Series B - Vor Biopharma
PureTech Health
PureTech Health investment in Series B - Vor Biopharma
Alexandria Venture Investments
Alexandria Venture Investments investment in Series B - Vor Biopharma
Johnson & Johnson Innovation – JJDC
Johnson & Johnson Innovation – JJDC investment in Series B - Vor Biopharma
RA Capital Management
RA Capital Management investment in Series B - Vor Biopharma
5AM Ventures
5AM Ventures investment in Series B - Vor Biopharma
Pagliuca Family Office
Pagliuca Family Office investment in Series B - Vor Biopharma
OUP (Osage University Partners)
OUP (Osage University Partners) investment in Series A - Vor Biopharma
5AM Ventures
5AM Ventures investment in Series A - Vor Biopharma
Official Site Inspections
http://www.vorbio.com Semrush global rank: 2.74 M Semrush visits lastest month: 5.93 K
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
